Preclinical and clinical studies have uncovered several gastrointestinal effects of metformin, including stimulation of the incretin hormone glucagon-like peptide-1 (GLP-1) [8], slowing of gastric emptying [8], suppression of intestinal glucose absorption [9], inhibition of bile acid resorption [10, 11] and modulation of the gut microbiota [12]
10.1055/s-2004-826172 217
Tirzepatide (Mounjaro, Zepbound) Tirzepatide targets both GLP-1 and GIP receptors, producing greater average weight loss than semaglutide in head-to-head trials, typically 20 to 25 percent of body weight
Anti-nausea foods can also help bridge the gap on difficult days
Real coverage verdicts for 40 US insurers and 35 of the most-searched drugs GLP-1s, diabetes, blood thinners, ADHD stimulants, biologics and more